prednisolone acetate has been researched along with Cataract in 29 studies
prednisolone acetate: RN given refers to cpd with locant for acetate group in position 21 & (11 beta)-isomer
Cataract: Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Difluprednate administered twice a day was at least as effective as prednisolone acetate administered 4 times a day for inflammatory treatment after cataract surgery." | 9.51 | Difluprednate 0.05% twice a day vs prednisolone acetate 1% 4 times a day for cataract postsurgical inflammation treatment: noninferiority trial. ( Del Papa, M; Ferroni, C; Ferroni, V; Idiart, C; Kaufer, R; Marino, F; Masseroni, M; Nuñez, M; Passerini, MS; Valvecchia, G; Zaldívar, R, 2022) |
| "5% with prednisolone acetate suspension (PA) 1% for the treatment of inflammation after cataract surgery in children." | 9.34 | Loteprednol etabonate gel 0.5% vs prednisolone acetate suspension 1% for the treatment of inflammation after cataract surgery in children. ( Vittitow, JL; Williams, JI, 2020) |
| "To evaluate and compare regulation of diabetes mellitus (DM) in dogs with cataracts and well-controlled DM that received an ophthalmic preparation of prednisolone acetate versus diclofenac sodium." | 9.30 | Evaluation of diabetes mellitus regulation in dogs treated with ophthalmic preparations of prednisolone acetate versus diclofenac sodium. ( Bello, NM; Fentiman, KE; Huey, JA; KuKanich, KS; Meekins, JM; Rankin, AJ; Schermerhorn, T, 2019) |
| "To compare the outcomes of congenital cataract surgery using intraoperative intracameral triamcinolone versus postoperative oral prednisolone to modulate ocular inflammation." | 9.19 | Outcomes of congenital cataract surgery: intraoperative intracameral triamcinolone injection versus postoperative oral prednisolone. ( Arantes, TE; Nosé, W; Ventura, BV; Ventura, CV; Ventura, LO; Ventura, MC, 2014) |
| "To investigate the relationship between vitamin E deficiency and prednisolone-induced cataract formation, long-term examination of lens changes was performed in rats under the condition of vitamin E deficiency or supplementation and administration of prednisolone." | 7.71 | Low vitamin E level as a subliminal risk factor in a rat model of prednisolone-induced cataract. ( Hockwin, O; Kojima, M; Murano, H; Nagata, M; Sasaki, K; Shui, YB; Takahashi, N, 2002) |
| "In order to induce experimental steroid cataracts in rat eyes similar morphologically to those seen in human eyes, prednisolone acetate was administered either topically or systemically for 12 months with a low dose of X-irradiation as a cocataractogenic factor." | 7.69 | A new steroid-induced cataract model in the rat: long-term prednisolone applications with a minimum of X-irradiation. ( Kojima, M; Sasaki, K; Shui, YB, 1996) |
| " Safety included evaluation of adverse events." | 6.82 | Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study. ( Gedif, K; Lambert, SR; Markwardt, K; O'Halloran, H; Plager, DA; Roarty, J; VanderVeen, D; Wilson, ME, 2016) |
| "Difluprednate administered twice a day was at least as effective as prednisolone acetate administered 4 times a day for inflammatory treatment after cataract surgery." | 5.51 | Difluprednate 0.05% twice a day vs prednisolone acetate 1% 4 times a day for cataract postsurgical inflammation treatment: noninferiority trial. ( Del Papa, M; Ferroni, C; Ferroni, V; Idiart, C; Kaufer, R; Marino, F; Masseroni, M; Nuñez, M; Passerini, MS; Valvecchia, G; Zaldívar, R, 2022) |
| "5% with prednisolone acetate suspension (PA) 1% for the treatment of inflammation after cataract surgery in children." | 5.34 | Loteprednol etabonate gel 0.5% vs prednisolone acetate suspension 1% for the treatment of inflammation after cataract surgery in children. ( Vittitow, JL; Williams, JI, 2020) |
| "To evaluate and compare regulation of diabetes mellitus (DM) in dogs with cataracts and well-controlled DM that received an ophthalmic preparation of prednisolone acetate versus diclofenac sodium." | 5.30 | Evaluation of diabetes mellitus regulation in dogs treated with ophthalmic preparations of prednisolone acetate versus diclofenac sodium. ( Bello, NM; Fentiman, KE; Huey, JA; KuKanich, KS; Meekins, JM; Rankin, AJ; Schermerhorn, T, 2019) |
| "Eyes having cataract surgery were randomly given an NSAID (bromfenac 0." | 5.22 | Effect of postoperative administration of nonsteroidal antiinflammatory drugs and steroids on the conformational changes in wound healing after cataract surgery. ( Choi, EY; Kang, HG; Kim, EK; Kim, TI; Lee, HK, 2016) |
| "To compare the outcomes of congenital cataract surgery using intraoperative intracameral triamcinolone versus postoperative oral prednisolone to modulate ocular inflammation." | 5.19 | Outcomes of congenital cataract surgery: intraoperative intracameral triamcinolone injection versus postoperative oral prednisolone. ( Arantes, TE; Nosé, W; Ventura, BV; Ventura, CV; Ventura, LO; Ventura, MC, 2014) |
| "In dogs that underwent cataract surgery via phacoemulsification, a full week of topical prednisolone acetate treatment prior to surgery did not decrease postoperative inflammation, compared with commencement of topical prednisolone acetate treatment the evening prior to surgery, and was associated with a greater incidence of postoperative ocular hypertension." | 5.16 | Effects of one-week versus one-day preoperative treatment with topical 1% prednisolone acetate in dogs undergoing phacoemulsification. ( Hendrix, DV; McLean, NJ; Vaughn, RK; Ward, DA, 2012) |
| "To investigate the relationship between vitamin E deficiency and prednisolone-induced cataract formation, long-term examination of lens changes was performed in rats under the condition of vitamin E deficiency or supplementation and administration of prednisolone." | 3.71 | Low vitamin E level as a subliminal risk factor in a rat model of prednisolone-induced cataract. ( Hockwin, O; Kojima, M; Murano, H; Nagata, M; Sasaki, K; Shui, YB; Takahashi, N, 2002) |
| " Initial presentation of the patient was bilateral iridocyclitis, for which he was treated with prednisolone acetate 1% every 2 hours for 6 months." | 3.70 | Systemic toxicity of topical and periocular corticosteroid therapy in an 11-year-old male with posterior uveitis. ( Cheng, L; Freeman, WR; Levi, L; Ozerdem, U; Scher, C; Song, MK, 2000) |
| "In order to induce experimental steroid cataracts in rat eyes similar morphologically to those seen in human eyes, prednisolone acetate was administered either topically or systemically for 12 months with a low dose of X-irradiation as a cocataractogenic factor." | 3.69 | A new steroid-induced cataract model in the rat: long-term prednisolone applications with a minimum of X-irradiation. ( Kojima, M; Sasaki, K; Shui, YB, 1996) |
| " Safety included evaluation of adverse events." | 2.82 | Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study. ( Gedif, K; Lambert, SR; Markwardt, K; O'Halloran, H; Plager, DA; Roarty, J; VanderVeen, D; Wilson, ME, 2016) |
| "To investigate the incidence and outcomes of cystoid macular edema (CME) after Descemet membrane endothelial keratoplasty (DMEK) alone and DMEK combined with cataract surgery (DMEK triple)." | 1.62 | Incidence and Outcomes of Cystoid Macular Edema after Descemet Membrane Endothelial Keratoplasty (DMEK) and DMEK Combined with Cataract Surgery. ( Bae, SS; Ching, G; Covello, AT; Holland, S; Iovieno, A; McCarthy, M; Ritenour, R; Yeung, SN, 2021) |
| " However, chronic use of topical corticosteroids dosed at <3 drops daily seemed to be associated with a lower risk of cataract development relative to eyes receiving higher doses over follow-up in the setting of suppressed uveitis." | 1.56 | Risk of Cataract Development among Children with Juvenile Idiopathic Arthritis-Related Uveitis Treated with Topical Corticosteroids. ( Dunn, JP; Jabs, DA; Thorne, JE; Woreta, FA, 2020) |
| "To analyze the effect of intensified topical steroid therapy after Descemet membrane endothelial keratoplasty combined with cataract surgery (triple-DMEK) on the incidence of postoperative cystoid macular edema (CME)." | 1.43 | Intensified Topical Steroids as Prophylaxis for Macular Edema After Posterior Lamellar Keratoplasty Combined With Cataract Surgery. ( Bachmann, BO; Cursiefen, C; Felsch, M; Hoerster, R; Siebelmann, S; Stanzel, TP, 2016) |
| " However, chronic use of topical corticosteroids dosed at < or = 3 drops daily seemed to be associated with a lower risk of cataract development relative to eyes receiving higher doses over follow-up in the setting of suppressed uveitis." | 1.36 | Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids. ( Dunn, JP; Jabs, DA; Thorne, JE; Woreta, FA, 2010) |
| "Data recorded were visual acuity (VA), recurrences and surgical complications." | 1.36 | [Pars plana vitrectomy as anti-inflammatory therapy for intermediate uveitis in children]. ( Arruabarrena, C; Contreras, I; Figueroa, MS; García-Pérez, JL; Gil-Cazorla, R; Noval, S; Sales, M, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.90) | 18.7374 |
| 1990's | 3 (10.34) | 18.2507 |
| 2000's | 7 (24.14) | 29.6817 |
| 2010's | 11 (37.93) | 24.3611 |
| 2020's | 6 (20.69) | 2.80 |
| Authors | Studies |
|---|---|
| Valvecchia, G | 1 |
| Kaufer, R | 1 |
| Ferroni, C | 1 |
| Zaldívar, R | 1 |
| Masseroni, M | 1 |
| Idiart, C | 1 |
| Ferroni, V | 1 |
| Marino, F | 1 |
| Nuñez, M | 1 |
| Del Papa, M | 1 |
| Passerini, MS | 1 |
| Hovanesian, JA | 1 |
| Donnenfeld, ED | 1 |
| Rankin, AJ | 1 |
| KuKanich, KS | 1 |
| Schermerhorn, T | 1 |
| Bello, NM | 1 |
| Huey, JA | 1 |
| Fentiman, KE | 1 |
| Meekins, JM | 1 |
| Thorne, JE | 2 |
| Woreta, FA | 2 |
| Dunn, JP | 2 |
| Jabs, DA | 2 |
| Vittitow, JL | 1 |
| Williams, JI | 1 |
| Ching, G | 1 |
| Covello, AT | 1 |
| Bae, SS | 1 |
| Holland, S | 1 |
| McCarthy, M | 1 |
| Ritenour, R | 1 |
| Iovieno, A | 1 |
| Yeung, SN | 1 |
| Grzybowski, A | 1 |
| Kanclerz, P | 1 |
| Lytvynchuk, L | 1 |
| Ventura, MC | 1 |
| Ventura, BV | 1 |
| Ventura, CV | 1 |
| Ventura, LO | 1 |
| Arantes, TE | 1 |
| Nosé, W | 1 |
| Hoerster, R | 1 |
| Stanzel, TP | 1 |
| Bachmann, BO | 1 |
| Siebelmann, S | 1 |
| Felsch, M | 1 |
| Cursiefen, C | 1 |
| Wilson, ME | 2 |
| O'Halloran, H | 2 |
| VanderVeen, D | 2 |
| Roarty, J | 2 |
| Plager, DA | 2 |
| Markwardt, K | 1 |
| Gedif, K | 1 |
| Lambert, SR | 2 |
| Ranjan, A | 1 |
| Murthy, SI | 1 |
| Rathi, VM | 1 |
| Sangwan, VS | 1 |
| Kaur, S | 1 |
| Sukhija, J | 1 |
| Choi, EY | 1 |
| Kang, HG | 1 |
| Kim, TI | 1 |
| Kim, EK | 1 |
| Lee, HK | 1 |
| Figueroa, MS | 1 |
| Noval, S | 1 |
| Contreras, I | 1 |
| Arruabarrena, C | 1 |
| García-Pérez, JL | 1 |
| Sales, M | 1 |
| Gil-Cazorla, R | 1 |
| McLean, NJ | 1 |
| Ward, DA | 1 |
| Hendrix, DV | 1 |
| Vaughn, RK | 1 |
| Lam, LA | 1 |
| Lowder, CY | 1 |
| Baerveldt, G | 1 |
| Smith, SD | 1 |
| Traboulsi, EI | 1 |
| Till, JS | 1 |
| Sowka, J | 1 |
| Vollmer, L | 1 |
| Falco, L | 1 |
| Lam, DS | 1 |
| Leung, DY | 1 |
| Tham, CC | 1 |
| Li, FC | 1 |
| Kwong, YY | 1 |
| Chiu, TY | 1 |
| Fan, DS | 1 |
| Nishigori, H | 1 |
| Lee, JW | 1 |
| Iwamoto, Y | 1 |
| Hayashi, R | 1 |
| Maruyama, K | 1 |
| Iwatsuru, M | 1 |
| Kojima, M | 4 |
| Shui, YB | 4 |
| Murano, H | 2 |
| Sasaki, K | 3 |
| Vrensen, GF | 1 |
| Ozerdem, U | 1 |
| Levi, L | 1 |
| Cheng, L | 1 |
| Song, MK | 1 |
| Scher, C | 1 |
| Freeman, WR | 1 |
| Caprioli, J | 1 |
| Samson, CM | 1 |
| Foster, CS | 1 |
| Araie, M | 1 |
| Rockwood, EJ | 1 |
| Nagata, M | 1 |
| Hockwin, O | 1 |
| Takahashi, N | 1 |
| Mondino, BJ | 1 |
| Farley, MK | 1 |
| Aizuss, DH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The D3 Study: Drug Delivery vs Drops - A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1% in Controlling Post-operative Pain and Inflammation in Patients Undergoing Sequential Cataract Surgery[NCT04273282] | Phase 4 | 31 participants (Actual) | Interventional | 2019-12-16 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 trials available for prednisolone acetate and Cataract
| Article | Year |
|---|---|
Difluprednate 0.05% twice a day vs prednisolone acetate 1% 4 times a day for cataract postsurgical inflammation treatment: noninferiority trial.
Topics: Cataract; Eye Diseases; Fluprednisolone; Humans; Inflammation; Phacoemulsification; Postoperative Co | 2022 |
Intracameral dexamethasone 9% vs prednisolone acetate 1% in controlling postoperative pain and inflammation in patients undergoing cataract surgery.
Topics: Cataract; Cataract Extraction; Dexamethasone; Humans; Inflammation; Moxifloxacin; Ophthalmic Solutio | 2022 |
Evaluation of diabetes mellitus regulation in dogs treated with ophthalmic preparations of prednisolone acetate versus diclofenac sodium.
Topics: Animals; Cataract; Diabetes Complications; Diabetes Mellitus; Diclofenac; Dog Diseases; Dogs; Double | 2019 |
Loteprednol etabonate gel 0.5% vs prednisolone acetate suspension 1% for the treatment of inflammation after cataract surgery in children.
Topics: Androstadienes; Cataract; Child; Double-Blind Method; Humans; Inflammation; Intraocular Pressure; Lo | 2020 |
Outcomes of congenital cataract surgery: intraoperative intracameral triamcinolone injection versus postoperative oral prednisolone.
Topics: Administration, Oral; Anterior Eye Segment; Cataract; Cataract Extraction; Cornea; Corneal Pachymetr | 2014 |
Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study.
Topics: Administration, Topical; Aphakia, Postcataract; Cataract; Cataract Extraction; Child, Preschool; Dou | 2016 |
Effect of postoperative administration of nonsteroidal antiinflammatory drugs and steroids on the conformational changes in wound healing after cataract surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract; Cataract Extraction | 2016 |
Effects of one-week versus one-day preoperative treatment with topical 1% prednisolone acetate in dogs undergoing phacoemulsification.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Cataract; Dog Diseases; Dogs; Drug Admin | 2012 |
Randomized trial of early phacoemulsification versus peripheral iridotomy to prevent intraocular pressure rise after acute primary angle closure.
Topics: Acute Disease; Aged; Antihypertensive Agents; Cataract; Female; Follow-Up Studies; Glaucoma, Angle-C | 2008 |
20 other studies available for prednisolone acetate and Cataract
| Article | Year |
|---|---|
Risk of Cataract Development among Children with Juvenile Idiopathic Arthritis-Related Uveitis Treated with Topical Corticosteroids.
Topics: Administration, Ophthalmic; Adolescent; Adult; Arthritis, Juvenile; Cataract; Child; Child, Preschoo | 2020 |
Incidence and Outcomes of Cystoid Macular Edema after Descemet Membrane Endothelial Keratoplasty (DMEK) and DMEK Combined with Cataract Surgery.
Topics: Administration, Ophthalmic; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Age | 2021 |
Methods for achieving low endophthalmitis rates in phacoemulsification cataract surgery.
Topics: Benzeneacetamides; Cataract; Endophthalmitis; Finland; Humans; Levofloxacin; Phacoemulsification; Ph | 2020 |
Intensified Topical Steroids as Prophylaxis for Macular Edema After Posterior Lamellar Keratoplasty Combined With Cataract Surgery.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Cataract; Corneal Diseases; Descemet Stripp | 2016 |
Acute Bilateral Toxic Endotheliitis Following Alcohol Consumption.
Topics: Acute Disease; Adult; Alcohol Drinking; Anti-Bacterial Agents; Cataract; Cataract Extraction; Cornea | 2018 |
Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study.
Topics: Anti-Inflammatory Agents; Cataract; Cataract Extraction; Child; Double-Blind Method; Fluprednisolone | 2017 |
Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study.
Topics: Anti-Inflammatory Agents; Cataract; Cataract Extraction; Child; Double-Blind Method; Fluprednisolone | 2017 |
Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids.
Topics: Administration, Topical; Adolescent; Adult; Arthritis, Juvenile; Cataract; Child; Child, Preschool; | 2010 |
[Pars plana vitrectomy as anti-inflammatory therapy for intermediate uveitis in children].
Topics: Adolescent; Anti-Inflammatory Agents; Cataract; Child; Child, Preschool; Combined Modality Therapy; | 2010 |
Surgical management of cataracts in children with juvenile rheumatoid arthritis-associated uveitis.
Topics: Administration, Topical; Anti-Inflammatory Agents; Arthritis, Juvenile; Capsulorhexis; Cataract; Chi | 2003 |
Collamer intraocular lens implantation with active uveitis.
Topics: Cataract; Female; Glucocorticoids; Humans; Iritis; Laser Therapy; Lens Capsule, Crystalline; Lens Im | 2003 |
Rapid onset phacolysis.
Topics: Autoantibodies; Autoantigens; Cataract; Cataract Extraction; Crystallins; Female; Glaucoma; Glucocor | 2004 |
Alteration of hepatic lipidperoxide levels during cataract formation caused by glucocorticoids in developing chick embryos.
Topics: Animals; Cataract; Chick Embryo; Dexamethasone; Glucocorticoids; Hydrocortisone; Lipid Peroxides; Li | 1984 |
Inhibition of steroid-induced cataract in rat eyes by administration of vitamin-E ophthalmic solution.
Topics: Animals; Body Weight; Cataract; Disease Models, Animal; Glucocorticoids; Lens, Crystalline; Light; M | 1996 |
A new steroid-induced cataract model in the rat: long-term prednisolone applications with a minimum of X-irradiation.
Topics: Animals; Blood Glucose; Body Weight; Cataract; Disease Models, Animal; Glucocorticoids; Image Proces | 1996 |
Experimentally induced steroid cataract in the rat: a scanning electron microscopic study.
Topics: Administration, Topical; Animals; Cataract; Glucocorticoids; Lens, Crystalline; Male; Microscopy, El | 1997 |
Systemic toxicity of topical and periocular corticosteroid therapy in an 11-year-old male with posterior uveitis.
Topics: Acanthosis Nigricans; Administration, Topical; Anti-Inflammatory Agents; Cataract; Child; Cushing Sy | 2000 |
Uveitis and glaucoma.
Topics: Antihypertensive Agents; Cataract; Cataract Extraction; Cyclopentolate; Drug Therapy, Combination; F | 2000 |
Low vitamin E level as a subliminal risk factor in a rat model of prednisolone-induced cataract.
Topics: Animals; Body Weight; Cataract; Glucocorticoids; Lens, Crystalline; Male; Prednisolone; Rats; Rats, | 2002 |
Sectorial corneal infiltrates and pannus in herpes zoster ophthalmicus.
Topics: Adolescent; Cataract; Cataract Extraction; Cornea; Corneal Transplantation; Herpes Zoster Ophthalmic | 1986 |